Eisen; Herman N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Eisen; Herman N..The latest application filed is for "rnai-based therapeutics for allergic rhinitis and asthma".

Company Profile

0.12.10

Eisen; Herman N. - Waban MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
RNAi-BASED THERAPEUTICS FOR ALLERGIC RHINITIS AND ASTHMA App 20110112169 - Chen; Jianzhu ; et al.	2011-05-12
Influenza Therapeutic App 20100204297 - Chen; Jianzhu ; et al.	2010-08-12
Influenza Therapeutic App 20090124567 - Chen; Jianzhu ; et al.	2009-05-14
Influenza Therapeutic App 20090106852 - Chen; Jianzhu ; et al.	2009-04-23
Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent Grant 7,501,125 - Huang , et al. March 10, 2	2009-03-10
Influenza therapeutic App 20060160759 - Chen; Jianzhu ; et al.	2006-07-20
RNAi-based therapeutics for allergic rhinitis and asthma App 20060058255 - Chen; Jianzhu ; et al.	2006-03-16
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent Grant 6,875,435 - Huang , et al. April 5, 2	2005-04-05
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent App 20050048079 - Huang, Qian ; et al.	2005-03-03
Compositions and methods for delivery of short interfering RNA and short hairpin RNA App 20050008617 - Chen, Jianzhu ; et al.	2005-01-13
Influenza therapeutic App 20040242518 - Chen, Jianzhu ; et al.	2004-12-02
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent App 20020146426 - Huang, Qian ; et al.	2002-10-10
Heterodimeric T lymphocyte receptor Grant 5,882,945 - Saito , et al. March 16, 1	1999-03-16
Meterodimeric T lymphocyte receptor antibody Grant 5,189,147 - Saito , et al. February 23, 1	1993-02-23
Heterodimeric T lymphocyte receptor Grant 4,970,296 - Saito , et al. November 13, 1	1990-11-13
System for controlled release of biologically active compounds Grant 4,933,185 - Wheatley , et al. June 12, 1	1990-06-12
System for delayed and pulsed release of biologically active substances Grant 4,921,757 - Wheatley , et al. May 1, 1	1990-05-01
System for delayed and pulsed release of biologically active substances Grant 4,900,556 - Wheatley , et al. February 13, 1	1990-02-13
T lymphocyte receptor subunit Grant 4,874,845 - Saito , et al. October 17, 1	1989-10-17
Heterodimeric T lymphocyte receptor Grant 4,873,190 - Saito , et al. * October 10, 1	1989-10-10
Cytotoxic t lymphocyte serine esterase and method for stimulation and inhibition Grant 4,783,410 - Pasternack , et al. November 8, 1	1988-11-08
Production and use of monoclonal antibodies to phosphotyrosine-containing proteins Grant 4,543,439 - Frackelton, Jr. , et al. Sept	1985-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.